Notícias

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is not always confined to the respiratory system, as it impacts people...

SARS-CoV-2 is the third coronavirus to have caused severe disease in humans in the last two decades, with approximately 5%...

COVID-19, for which no confirmed therapeutic agents are available, has claimed over 48,14,000 lives globally. A feasible and quicker method...

The 2019 outbreak of coronavirus disease (COVID-19) in Wuhan (Hubei province of China) has given rise to a pandemic spread...

By December 2019, humanity was challenged by a new infectious respiratory disease named coronavirus disease of 2019 or COVID-19. This...

Nowadays, one of the major global health concerns is coronavirus disease 2019 (COVID-19), which is caused by the severe acute...

A Blau Farmacêutica (B3: BLAU3), uma das principais indústrias farmacêuticas da
América Latina focada na produção de medicamentos de...

ABIFINA contribui para o Plano Estratégico da Farmacopeia Brasileira. Documento
quinquenal é publicado no site da Anvisa contendo objetivos,...

We report the clinical efficacy against COVID-19 infection of BBV152, a whole virion inactivated SARS-CoV-2 vaccine formulated with a toll-like...

Concomitant administration of COVID-19 and influenza vaccines could reduce burden on health-care systems. We aimed to assess the safety of...

Ourofino Saúde Animal foi eleita a melhor empresa das Américas Latina e do Sul no
Animal Health Award. Inovação...

Cinco associados da ABIFINA são signatários do Pacto Global e integram sua Rede
Brasil: Blanver, Eurofarma, Instituto de Biologia...